** Shares of medical devices maker Nanosonics NAN.AX fall 4.3% to A$4.64
** Bell Potter forecasts additional A$2.5 million ($1.59 million) to co's costs in FY26 due to U.S. tariffs on Australia
** Also sees co's new 'CORIS' devices to have minimal contribution to revenue in FY26
** Downgrades FY26 and FY27 earnings by 9%; reduces PT to A$4.05 from A$4.06
** Three analysts rate the stock "buy", 4 "hold" and 2 "sell"; their median PT is A$4.78 – LSEG data
** Stock trims YTD gains to 52.8%
($1 = 1.5726 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。